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Objective: To analyze the costs treatment for patients 
with Acute Myocardial Infarction (AMI) over the period 
from 2000 to 2016.
Materials and methods: Systematic review of the lit-
erature on the costs of treatment for patients with Acute 
Myocardial Infarction in the period 2000-2016. We se-
lected 30 scientific articles from the database Scielo, Med-
line, Redalyc, Springer Medizin and Lilacs, which met the 
inclusion criteria: articles published in Spanish, Portuguese 
or English from 2000 to 2016. To restrict the search of 
articles, we use the health descriptors: costs, myocardial 
infarction and cardiovascular, combining them with the 
Boolean operators ‘’AND’’, ‘’OR’’ and ‘’NOT’’. Of which, a 
sample of 11 articles was selected. 
Results: It was evidenced that a high percentage (63.6%) 
came from the Scielo database. According to the country 
of origin of the articles, it was identified that the highest 
percentage (36.4%) came from Colombia. Concerning 
the direct and indirect costs of patients with Acute Myo-
cardial Infarction (AMI) from an international perspective, 
the total estimated cost for Acute Coronary Syndrome 
(ACS) in 2011, including direct and indirect costs, is $1.26 
million (US dollars are used throughout). In Colombia, the 
average cost of a case of AMI during the first five years af-
ter diagnosis is USD $8,786.9. Ambulatory management 
costs represent 54%. 
Conclusion: The costs of people with Acute Myocardial 
Infarction in both ambits, the international and national 
(Colombia) are significantly attributable by surgical in-
terventions, treatment, hospital stay and post-diagnostic 
outpatient management.
Key words: Costs, myocardial infarction, cardiovascular.
Objetivo: Analizar los costos del tratamiento para pa-
cientes con Infarto Agudo de Miocardio (IAM) durante el 
período 2000 a 2016.
Materiales y métodos: Revisión sistemática de la litera-
tura sobre los costos del tratamiento para pacientes con 
Infarto Agudo de Miocardio en el período 2000-2016. Se-
leccionamos 30 artículos científicos de la base de datos 
Scielo, Medline, Redalyc, Springer Medizin y Lilacs, que 
cumplieron con los criterios de inclusión: artículos publica-
dos en español, portugués o inglés de 2000 a 2016. Para 
restringir la búsqueda de artículos, utilizamos los descrip-
tores de salud: costos, infarto de miocardio y cardiovascu-
lar, combinándolos con los operadores booleanos ‘’AND’’, 
‘’OR’’ y ‘’NOT’’. De los cuales, se seleccionó una muestra 
de 11 artículos. 
Resultados: Se evidenció que un alto porcentaje (63.6%) 
provino de la base de datos Scielo. De acuerdo con el país 
de origen de los artículos, se identificó que el porcentaje 
más alto (36.4%) provino de Colombia. Con respecto a 
los costos directos e indirectos de los pacientes con Infarto 
Agudo de Miocardio (IAM) desde una perspectiva interna-
cional, el costo total estimado para el Síndrome Coronario 
Agudo (SCA) en 2011, incluidos los costos directos e indi-
rectos, es de $ 1.26 millones (se utilizan dólares estadou-
nidenses en todo). En Colombia, el costo promedio de un 
caso de IAM durante los primeros cinco años después del 
diagnóstico es de USD $8,786.9. Los costos de manejo 
ambulatorio representan el 54%. 
Conclusión: Los costos de las personas con Infarto Agu-
do de Miocardio en ambos ámbitos, el internacional y el 
nacional (Colombia) se pueden atribuir significativamente 
a las intervenciones quirúrgicas, el tratamiento, la estancia 
hospitalaria y el tratamiento ambulatorio post-diagnóstico.
Palabras clave: Costos, infarto de miocardio, cardiovascular.
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cute Myocardial Infarction (AMI) is 
the necrosis of myocardial cells as a 
consequence of prolonged ischemia 
caused by the sudden reduction of coronary blood supply, 
which involves one or more areas of the myocardium1.
According to figures presented by the World Health Or-
ganization (WHO), AMI occurs with high prevalence at an 
early age, precisely when the person is in the process of 
family structuring and has optimal health status for work 
performance. It is estimated that by 2020 the prevalence 
could increase to 11.1 million people per year2.
In 2006, a total of 146,000 AMIs were estimated for years 
in the United Kingdom. The incidence is higher in men 
than in women and increases with age. Likewise, in Scot-
land and Ireland, incidence rates are higher than in the 
south of England. In Spain, the incidence of AMI ranges 
from 135-210 cases per 100,000 inhabitants3.
On the other hand, AMI is the most important cause of 
mortality in developed countries, as well as a great num-
ber of hospital admissions. In Spain each year there are 
around 140,000 deaths and 5 million hospitalizations due 
to the same cause, which corresponds to health care costs 
of 15% of total expenses, hospital readmissions in the 
medium term are very frequent in patients who survive 
AMI; the males, coronary disease background and the 
number of cardiovascular risk factors are predictive fac-
tors of re-entry risk4,5.
In Spain, the situation is alarming, it is estimated that in 
2013 there could be 115,752 cases of AMI (64% in men 
and 36% women), of which 86.2% would be cases of 
Acute Myocardial Infarction, of these would have died 
within the first month 38.7%6. Likewise, studies point to 
the risk factors for Coronary Arteriosclerotic Disease as a 
direct cause in the exposure of AMI in subjects over 45 
years of age. However, in individuals younger than 45 
years, the association is more frequent to hypercoagulable 
phenomena, vasculitis and vasospasm7, 8. 
A study about the prevalence of Acute Myocardial Infarc-
tion, carried out in the population of the cardiovascular 
risk program of a first level health services provider in-
stitution in the municipality of Armenia-Quindío during 
2014, determined that they consulted 11,765 people and 
presented 293 cases with a history of Myocardial Infarc-
tion, which represented a prevalence of 2.49%. Men cor-
responded to the highest percentage of people who have 
suffered a coronary event (57.62%), and at a younger age 
than women9.
It should be noted that AMI, because of its great complex-
ity and the economic repercussions, are highly significant, 
for the individual, his family and for the state or institu-
tions involved. For this reason, it is considered a disease 
of high direct and indirect cost. Direct costs are those ex-
penses originated by the payment of the work force that 
directly executes the actions, the consumptions of the 
materials used, the services and other obligations that can 
be directly associated to the activity that is executed (the 
state and institutions involved in the patient-disease pro-
cess); and indirect costs are expenses that cannot be di-
rectly associated with the execution of activities, originate 
in other organizational areas that support the actions of 
those who receive it (the individual and his family)10.
In a study conducted in Colombia on the costs of medi-
cal care for Acute Myocardial Infarction, it was evidenced 
that in the first five years after diagnosis the cost was USD 
$8,786.9. the cost of outpatient management being the 
most prevalent (54%); followed by management in the in-
tensive care units (23%); Surgery (8%); the handling in the 
hemodynamics room and the costs for diagnosis and stag-
ing in the emergency room of 9% and Hospitalization 6%11.
Regarding indirect costs, the information from the San 
Jorge de Pereira University Hospital (HUSJ) was used, where 
the corresponding day-bed occupied by a patient with cor-
onary disease was considered, on the total of the service. 
Costs were identified by indirect labor COP $20,040,789, 
indirect general expenses COP $27,807,825, administrative 
expenses COP $25,398,616, logistics COP $23,786,963, 
for a total of direct costs of COP $97,034,193 12.
A review of the direct and indirect costs of AMI is relevant 
considering its scope and economic impact on health in-
stitutions. This research is a method to describe the eco-
nomic impact of the disease in the distribution of the costs 
of the different types of used resources13. Likewise, it is a 
chronic intransmissible disease that, in general, tends to 
studied only in terms of its symptomatological, etiological 
and treatment aspects. Studies of the financial aspects are 
uncommon in the Literature. By the above, the objective 
of this study is to analyze the costs treatment for patients 
with Acute Myocardial Infarction (AMI) over the period 
from 2000 to 2016.
ystematic review of the literature on the costs 
of treatment for patients with Acute Myo-
cardial Infarction in the period 2000-2016. 
We selected 30 scientific articles from the Scielo, Medline, 
Redalyc, Springer Medizin and Lilacs databases, which 
met the inclusion criteria: articles published in Spanish, 
Portuguese or English from 2000 to 2016. To restrict the 
search for articles, we used the health descriptors: costs, 
myocardial infarction and cardiovascular, combining them 
with the Boolean operators ‘’AND’’, ‘’OR’’ and ‘’NOT’’. Of 
which, a sample of 11 articles was selected.
For the collection of the information, the stages described 























count, such as: interpretation, compilation of evidences, 
recompression of the phenomenon, reflection for the criti-
cal action and the social practice of the knowledge and 
naturalization of the objects of study; for which, the ma-
trix was elaborated with the articles, of which the follow-
ing information was identified: Database / Country, title, 
objectives, authors / year and conclusions (See annexes: 
Table 1)
Table 1. Matrix with the articles included in the review
Database/ 
Country Title Objectives Authors/Year Results/Conclusions
Scielo/Chile
Cost / effectiveness of a 
cardiovascular rehabilitation program 
for people After Acute Myocardial 
Infarction: A theoretical analysis
Determine the cost-effectiveness 
ratio of a theoretical proposal of the 
Cardiovascular Rehabilitation Program
Gómez, JM et al 
/ 2016
The annual cost of the cardiac rehabilitation center is CLP $ 64,407,065. The 
Increased Ratio of Cost Effectiveness (ICER), considering a reduction of the late 
mortality of 25%, is CLP $ 475,209.72 / AVG. Value that being less than the Gross 
Domestic Product per capita, is considered as a very cost effective intervention
Scielo/Cuba
Institutional cost of Acute Myocardial 
Infarction at the Institute of 
Cardiology and Cardiovascular 
Surgery
Determine the institutional cost of Acute 
Myocardial Infarction in patients treated 
at the Cardiology and Cardiovascular 
Surgery Institute in 2006.
Fernández 
García, A et al. 
/ 2008
The total cost of the patients care with acute myocardial infarction for the 
Cardiology and Cardiovascular Surgery Institute was mainly given by the 
time devoted to patient care, the number of highly qualified professionals and 
technicians needed in the management of the disease, and the treatments used.
Scielo / Brazil
Cost of the chain of procedures in 
the treatment of Acute Myocardial 
Infarction in Brazilian hospitals of 
excellence and specialized
It presents the methodology and the 
results of a field survey to evaluate the 
costs of the chain of procedures for the 
treatment Of Acute Myocardial Infarction 
(AMI).
Marqués, R et 
al. /   2012
Overall, the total costs of the procedures that comprise the «standard treatment» 
of AMI totaled R $ 12,873.69 if Percutaneous Coronary Intervention (PCI) did not 
involve stent use. If this becomes necessary, the cost rises to R $ 23,461.87.
Scielo / 
Colombia
Costs of Chronic Intrasmissible 
Disease: the Colombian reality
Reflect on the social and economic costs 
of Chronic No Communicable Disease 
(CNCD) in Colombia to visualize a load 
indicator of these pathologies
Gallardo Solarte, 
K et al. / 2016
Chronic Intrasmissible Diseases represent a burden for the health service system 
due to very high costs, late intervention and reduced significant benefit for this 
population and their families.
Medline/ 
Switzerland
Determinants of Costs and the 
Length of Stay in Acute Coronary 
Syndromes: A Real Life Analysis of 
More Than 10 000 Patients
The aim of this study was to investigate 
inpatient costs of Acute Coronary 
Syndromes (ACS) in Switzerland and to 
assess the main cost drivers associated 
with this disease
Bramkamp,  M 
et al. / 2007
Mean total costs per patient were 12.101 Euro (median 10.929 Euro; 95% CI: 
1.161-27.722 Euro). The length of stay ranged from one to 129 days with a mean 




The costs of Myocardial 
Infarction—a longitudinal analysis 
using data from a large German 
health insurance company
The aim of the study was to measure 
the course of costs after a myocardial 
infarction
Reinhold, T et al. 
/  2011
Myocardial Infarction is associated with significant economic costs from the 
perspective of statutory health insurance. This cost burden particularly occurs 
within the first 2 weeks following a first myocardial infarction. For this reason, 
efficient management of the acute event is outstandingly important.
Lilacs/Colombia
Costs of lung cancer care, COPD 
and AMI attributable to tobacco use 
in Colombia
The purpose of this article is to present 
a cost definition exercise applicable 
to clinical practice in three diseases 
related to smoking: lung cancer, Acute 
Myocardial Infarction (AMI) and Chronic 
Obstructive Pulmonary Disease (COPD).
Pérez, Nicolás 
et al. / 2007
The average cost of AMI case during the first five years after diagnosis is USD $ 
8,786.9. Outpatient management costs represent 54%; management in the ICU, 
23%; surgery, 8%; general hospitalization, 6%; management in the catheterization 
room (for scheduled angioplasty), 5%, and costs for diagnosis and staging in the 
emergency room, 4%
Scielo/Brazil
Costs of Treatment of Acute 
Coronary Syndrome from the 
perspective of the Supplementary 
Health System
Evaluate costs and time of hospitalization 
between groups of patients who 
underwent ACS undergoing angioplasty 
procedures with or without stent 
implantation (stent +/- stent-), 
revascularization (Revasc) and treated 
only clinically (Clinical) from the 
perspective of the System Health Care 
System (SSS).
Teich, V et al.
/ 2015
The average costs per patient were R $ 18,261.77, R $ 30 611.07, R $ 37 454.94 
and R $ 40 883.37 in the Clinical, stent-, stent + and Revasc groups, respectively. 
The average costs per day of hospitalization were R $ 1987.03, R $ 4024.72, R $ 
6033.40 and R $ 2663.82, respectively. The mean hospitalization time was 9.19 
days, 7.61 days, 6.19 days and 15.20 days in those same groups. The differences 
were statistically significant among all groups, except Clinical and stent- and 
between the stent + and Revasc groups, for cost analysis.
Scielo/ Brazil Cost Estimate of Acute Coronary Syndrome in Brazil
Estimate the cost of SCA in Brazil 
and its impact on the Brazilian Health 
System in 2011, considering direct and 
indirect costs from the public and private 
perspective
Teich, V et al. 
/ 2011
The estimate of the direct cost associated with Acute Coronary Syndrome in 2011 
under the SUS perspective is R $ 522,286,726, approximately 0.77% of the total 
SUS budget. For the Supplementary Health System this estimate is R $ 515 138 
617. The indirect costs total R $ 2.8 billion, from the perspective of society. The 
total estimated cost for SCA in 2011, including direct and indirect costs, is R $ 
3.8 billion.
Scielo/Colombia
Expenditure by procedure in the 
specialty of interventional cardiology 
in patients with Coronary Disease of 
Social Security, Sectional Valle del 
Cauca. November 2003-December 
2004
Analyze the Expenditures by procedure 
in the specialty of interventional 
cardiology in patients with Coronary 




The ISS paid the IPS who provide interventional cardiology services the sum of 
COP $ 5 320 786 046 (more than five billion pesos) for the procedures performed, 
99.3% of which were performed on patients over 40 years of age. This canceled 




Projection of costs in Colombia for 
the initial care of Acute Coronary 
Syndrome.
Make an estimate of the average and 
total medical cost that the first attention 
of these acute events means for 
Colombia.
Castellanos 
Ramírez, J C. 
/ 2011
General average overall cost was COP $ 7 781 230, medications COP $ 1 948 
366 and antiaggregants COP $ 103 572. The cost of SCA care in Colombia has 
an average position in the referents used, although the presentation is estimated 
that means a year an important medical cost of close to a quarter of a billion 
dollars for the country and more than forty million dollars for Bogota
Source: Prepared by the research group.
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Socio demographic data
From the 11 articles used for the review, a high percentage 
(63.6%) came from the Scielo database and the remain-
ing 36.4% from the Medline database, Springer Medizin, 
Lilacs, Redalycs, as shown in Table 2.
Table 2: Number of articles reviewed according to the 
consulted databases
Database N° Reviewed Articles Percentage
Scielo 7 63,6%
Medline 1 9,1%
Springer Medizin 1 9,1%
Lilacs 1 9,1%
Redalycs 1 9,1%
Total Articles Reviewed 11 100%
Source: Prepared by the research group
According to the country of origin of the articles, it was 
identified that the highest percentage (36.4%) came from 
Colombia, followed by Brazil (27.2%) and the remain-
ing (36.4%) from Chile, Cuba, Switzerland and Germany 
(Table 3). 
Table 3. Reviewed articles by country of origin







Source: Prepared by the research group
Direct and indirect costs of patients with Acute Myocardial 
Infarction (AMI) from an international perspective
In Brazil, the estimate of the direct cost associated with 
AMI in 2011 is R $522.286.726 (USD $132.473.649,93 
for 2019) approximately 0.77% of the total budget of 
the single health system (SUS). For the Supplementary 
Health System this estimate is R $515.138.617 (USD 
$130.660.592,00 for 2019). Indirect costs total R $2.8bil-
lion (USD $710.493.357.124,19 for 2019), from the per-
spective of society. The total estimated cost for SCA in 
2011, including direct and indirect costs, is R $ 3.8billion 
(USD $964.240.984.668,54 for 2019)14.
According to time, the highest economic cost occurs par-
ticularly within the first two weeks and is totally significant 
from the perspective of Germany’s compulsory health in-
surance15. Among the variables to which this may be due, 
is given mainly by the time dedicated to patient care, the 
number of highly qualified professionals and technicians 
needed in the management of the disease, and the treat-
ments used16.
Regarding the costs attributable to treatments, specifically 
those of intervention (surgical) in Brazil, the average cost 
per patient with AMI was R $18.261,77(USD $4.629,82 
for 2019), R $30.611,07(USD $7.760,99 for 2019), R 
$37.454,94(USD $9.497,11 for 2019) and R $40.883,37 
(USD $10.366,60 for 2019) in the Clinical, Stent-, Stent + 
and Revasc groups, respectively17. However, for the proce-
dures that make up the “standard treatment” of the AMI, 
it amounted to R $12.873,69 (USD $ 3.264,17 for 2019) 
if the Percutaneous Coronary Intervention (PCI) did not 
imply the use of a stent. In case this is necessary, the cost 
rises to R $23.461,87 (USD $ 5.948,95 for 2019), that is, 
the cost is doubled18.
On the other hand, the costs attributable to hospitaliza-
tion in general terms are approximately R $14.708.97 
(USD $3.729,47 for 2019) with average hospitalization 
times of 9.54 days17. Likewise, in Switzerland for this 
same reason, the average total costs per patient were EUR 
$12.101 euros (USD $12.525,53, 2019) median of EUR 
$10,929 (USD $12.215,56 for 2019), 95% CI: 1.161 (USD 
$1.297,67 for 2019)-EUR $27.722 (USD $30.985,43 for 
2019), noting that the average hospital stay is 9.5 days 
(median of 8.0 days, 95% CI: 1-23)19.
Finally, the yearly costs attributable to cardiac rehabilita-
tion in Chile are CLP $64.407.065 (USD $95.030,28 for 
2019). The Incremental Reason for Cost Effectiveness 
(ICER), considering a reduction in late mortality of 25%, is 
CLP $475.209,72 (USAD $701,10 for 2019). Value that, 
being less than the gross domestic product per capita, is 
considered as a very cost effective intervention20.
Direct and indirect costs of patients with Acute Myocardial 
Infarction (AMI) from a national perspective (Colombia)
Today in Colombia, chronic intransmissible diseases, in-
cluding AMI, represent a burden for the health service sys-
tem due to very high costs, late intervention and reduced 
significant benefit for this population and their families21.
The average cost of AMI case during the first five years 
after diagnosis is USD $8 786.9 (USD / COP 2006 -2007). 
Outpatient management costs represent 54%; manage-
ment in the ICU, 23%; surgery, 8%; general hospitaliza-
tion, 6%; the management in the catheterization room 
(for programmed angioplasty), 5%, and the costs for di-
agnosis and staging in the emergency room, 4%11.
The cost of acute SCA care in Colombia has an average 
position in the referents used, although what is presented 
is estimated to mean an important medical cost of about 
a quarter of a billion dollars for the country and more than 
forty million dollars for Bogotá 22.
In other regions of Colombia, as in the case of Valle del 
Cauca, the Social Insurance Institute (ISS) paid the Health-
care Institutions (IPS) that provide interventional cardiolo-
gy services (surgical) for the sum of COP $ 5.320.786.046 
(more than five billion pesos) (USD $1.642.548,74 for 
2019)   for the procedures performed. This canceled mon-











he treatment costs of people with AMI in Co-
lombia and elsewhere account for a high pro-
portion of the total costs of health institutions 
and in more specific terms for the state. The major signifi-
cant components of the total treatment cost are surgical 
interventions, the treatment pharmacological, the hospi-
tal stay and post-diagnostic ambulatory management. 
On the other hand, it was evident during the review that 
little information could be found regarding the indirect 
costs that the AMI generates at the economic level of the 
patient and his family. Therefore, one of the recommen-
dations is to conduct research that investigates this prob-
lem in order to have a clearer and more complete view of 
the indirect costs of AMI.
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